Why I'm kicking myself I missed out on CSL shares

I'm still kicking myself on selling out of CSL Limited (ASX:CSL) shares. Here's why.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was March 2015, my hair was long, summer was on the run and I was about to buy my first bunch of ASX shares. After doing some reading and research, I had narrowed my selection to 5 or 6 ASX shares that I considered worthy of my first investment dollars.

Among this list was biotech company CSL Limited (ASX: CSL). I was enamoured with the company's products, its already impressive stock price growth and its dominance in the medical space and so went ahead and purchased about 35 shares at around $94 (read it and weep).

The CSL story

CSL is a true innovator and its blood plasma production remains one of the best and most fortified earning streams amongst medical stocks on the ASX. CSL's work with researching and manufacturing influenza vaccines through its Seqirus division places it at the forefront of the fight against the flu (this year's deadly flu season is a tragic reminder of the importance of this work).

Fast forward about three years and CSL had been my standout stock performer. Most of the other (in hindsight, pretty poor) stock picks had either gone backwards or stayed depressingly static – but CSL had charged ahead. I watched the stock price climb to $120, then to $140. At $150 I had thoughts about 'cashing out' and 'taking the profit', because that what the pros do and I thought I was a bit of a genius for latching onto such a winner. Finally, I relented and sold out at $161, taking an 80% profit and feeling pretty good. The price-to-earnings (P/E) ratio for CSL was very high (sitting around 40 if I remember) and I thought that I had ridden the wave to its height and it was about to crash, and I may as well take the cash off the table.

Alas, I then had to endure watching CSL smash through the $200 mark, then $220 and finally $230. Although CSL has since pulled back, it still has a P/E ratio in the high 30s and I learnt my lesson…

Foolish takeaway

If you get a fantastic company on the cheap, never, ever sell unless you have to! Good companies give back by compounding your money in a continuous cycle and the longer you hold the shares, the richer you will become. I wish I could go back and not hit the sell button – I have spent the last two years waiting for a 'buy-the-dip' opportunity to get back in (that still hasn't materialised). But such is life…

Sebastian Bowen (sadly) has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

Read more »

a man with a wide, eager smile on his face holds up three fingers.
Growth Shares

3 ASX shares to buy in 2024 and hold for the next 10 years

Analysts think these top shares are in the buy zone right now.

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Growth Shares

4 ASX growth shares I think will benefit from interest rate cuts in 2024

Not only will home loan holders rejoice, investors of these stocks could also be yelling with joy when the Reserve…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Growth Shares

3 of the best ASX growth shares to buy now

Analysts see plenty of upside for these buy-rated shares.

Read more »

A man and woman in an office look at a laptop and discuss investing, budget strategies or other financial concepts
Growth Shares

Here's why analysts love these buy-rated ASX 200 growth shares

There's a reason analysts are feeling bullish about these companies.

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Growth Shares

Big returns could be coming for high-flying Lovisa shares

Morgans doesn't believe it is too late to snap up this hot stock.

Read more »

Smiling young parents with their daughter dream of success.
Growth Shares

Why these ASX 200 growth shares could be top buys now

Analysts are feeling bullish about these growth stocks. Let’s see what they’re saying.

Read more »

Concept image of a man in a suit with his chest on fire.
Growth Shares

Ignore the noise and buy this hot ASX growth stock

A recent pullback may have created a buying opportunity according to Bell Potter.

Read more »